Vir Biotechnology, Inc.
VIR • NASDAQ • Stock Fundamentals
Vir Biotechnology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marianne De Backer, with a market cap of $1.4B.
Market Cap$1.4B
Employees587.0
CEOMarianne De Backer
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Vir Biotechnology, Inc. FAQ
Common questions about Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR) has a market capitalization of $1.4B and trades on NASDAQ.
Vir Biotechnology, Inc. has approximately 587 employees.